Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Accepted on 28 Feb 2025

The Impact of Phthalates on Asthma and Chronic Obstructive Pulmonary Disease: A Comprehensive Analysis Based on Network Toxicology and Molecular Docking

in Respiratory Pharmacology

Zhihong Zhang
Ren Li
Bingqing Zheng
Yuqiong Zhang
Lu He
Chaomin Ren
Linlin Guan
Huan Yang
Jiayu Tian
Xingyi Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1566965

Case Report

Published on 27 Feb 2025

Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report

in Respiratory Pharmacology

Zhe Zhao
Longbin Pang
Surui Liu
Jie Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443609

237 views

Original Research

Accepted on 18 Feb 2025

Rutin attenuates bleomycin-induced acute lung injury via miR-9-5p mediated NF-κB signaling inhibition: Network pharmacology analysis and experimental evidence

in Respiratory Pharmacology

Fatema S. Alatawi
Awatif M.E. Omran
Eman Rashad
Omnia N. Abdel-Rahman
Ahmed F. Soliman

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1522690

Review

Published on 18 Feb 2025

Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting

in Respiratory Pharmacology

Min Qiang
Zhe Chen
Hongyang Liu
Junxue Dong
Kejian Gong
Xinjun Zhang
Peng Huo
Jingjun Zhu
Yifeng Shao
Jinazun Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516583

246 views

Editorial

Published on 14 Feb 2025

Editorial: Lung microbiome in health and disease

in Respiratory Pharmacology

Kurtis Francis Budden
Luigina Romani

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565849

205 views

Original Research

Accepted on 05 Feb 2025

Assessing Medication Adherence in Adults with Asthma and Its Effect on Rescue Therapy for Exacerbations Koh

in Respiratory Pharmacology

Yi Ling Eileen Koh
Kian Yong Kenny Chua
Ng Ding Xuan
Wai Keong Aau
Ngiap Chuan Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516062

Case Report

Published on 05 Feb 2025

A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1

in Respiratory Pharmacology

Pei Zhu
Qingming Sun
Sheng Xu
Wanhui Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1508558

431 views

Review

Published on 29 Jan 2025

Silicosis: from pathogenesis to therapeutics

in Respiratory Pharmacology

Bijun Yang
Xiaoman Liu
Cheng Peng
Xiangjing Meng
Qiang Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516200

613 views

Mini Review

Published on 20 Jan 2025

The potential role of nanobodies in asthma therapy

in Respiratory Pharmacology

Baraa Khalid Salah Al-Sheakly
Fatemeh Saheb Sharif-Askari
Narjes Saheb Sharif-Askari
Jennifer E. Hundt
Rabih Halwani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1510806

766 views

Editorial

Published on 14 Jan 2025

Editorial: Methods in respiratory pharmacology 2023

in Respiratory Pharmacology

Nadia Milad
Giulio Cabrini
Maria Cordina

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527053

298 views

Original Research

Published on 13 Jan 2025

CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway

in Respiratory Pharmacology

Hao Qu
Yan Fang
Feng Zhang
Wenwen Liu
Shengkai Xia
Wenzhe Duan
Kun Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502165

720 views

Editorial

Published on 13 Jan 2025

Editorial: Model organisms in respiratory pharmacology 2023

in Respiratory Pharmacology

Alexandra McCarron
Ranu Surolia
Livia Ruffini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1540222

377 views

Original Research

Published on 09 Jan 2025

High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database

in Respiratory Pharmacology

Zhishen Ruan
Chunbin Wang
Shasha Yuan
Yiling Fan
Bo Xu
Xiaodong Cong
Dan Li
Qing Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1460407

947 views

Original Research

Published on 08 Jan 2025

Unphysiological lung strain promotes ventilation-induced lung injury via activation of the PECAM-1/Src/STAT3 signaling pathway

in Respiratory Pharmacology

Gang Liu
Bin-Bin Dong
Zi-Heng Ding
Chao Lan
Chang-Ju Zhu
Qi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469783

470 views

Original Research

Published on 07 Jan 2025

Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin

in Respiratory Pharmacology

Liliane Patrícia Gonçalves Tenório
Felipe Henrique da Cunha Xavier
Mônica Silveira Wagner
Kayo Moreira Bagri
Erick Gabriel Alves Ferreira
Romulo Galvani
Claudia Mermelstein
Adriana Cesar Bonomo
Wilson Savino
Emiliano Barreto

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504556

526 views

Original Research

Published on 03 Jan 2025

A novel non-invasive murine model for rapidly testing drug activity via inhalation administration against Mycobacterium tuberculosis

in Respiratory Pharmacology

Xirong Tian
Yamin Gao
Chunyu Li
Wanli Ma
Jingran Zhang
Yanan Ju
Jie Ding
Sanshan Zeng
H. M. Adnan Hameed
Htin Lin Aung

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400436

672 views

Navigation group

Articles

The Impact of Phthalates on Asthma and Chronic Obstructive Pulmonary Disease: A Comprehensive Analysis Based on Network Toxicology and Molecular Docking

Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report

Rutin attenuates bleomycin-induced acute lung injury via miR-9-5p mediated NF-κB signaling inhibition: Network pharmacology analysis and experimental evidence

Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting

Editorial: Lung microbiome in health and disease

Assessing Medication Adherence in Adults with Asthma and Its Effect on Rescue Therapy for Exacerbations Koh

A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1

Silicosis: from pathogenesis to therapeutics

The potential role of nanobodies in asthma therapy

Editorial: Methods in respiratory pharmacology 2023

CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway

Editorial: Model organisms in respiratory pharmacology 2023

High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database

Unphysiological lung strain promotes ventilation-induced lung injury via activation of the PECAM-1/Src/STAT3 signaling pathway

Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin

A novel non-invasive murine model for rapidly testing drug activity via inhalation administration against Mycobacterium tuberculosis